Sorbent Therapeutics Secures $6,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=19db2039-a9c7-4e3c-bcf0-63bc608aedce&Preview=1
Date
6/11/2012
Company Name
Sorbent Therapeutics
Mailing Address
710 Lakeway Drive Sunnyvale, CA 94085
Company Description
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
Website
http://www.sorbentrx.com
Transaction Type
Debt
Transaction Amount
$6,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed